An official website of the United States government
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2012
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| California | 368 | 57.6 | 4.0 | (49.8 – 65.4) | 387 | 57.1 | 3.9 | (49.5 – 64.7) |
| Hawaii | 227 | 49.1 | 6.1 | (37.1 – 61.1) | 241 | 55.8 | 4.8 | (46.4 – 65.2) |
| Illinois | 218 | 54.4 | 5.2 | (44.2 – 64.6) | 234 | 48.3 | 5.8 | (36.9 – 59.7) |
| Indiana | 332 | 56.0 | 3.9 | (48.4 – 63.6) | 360 | 52.6 | 3.8 | (45.2 – 60.0) |
| Iowa | 234 | 55.0 | 4.6 | (46.0 – 64.0) | 243 | 53.1 | 4.5 | (44.3 – 61.9) |
| Michigan | 553 | 62.3 | 3.1 | (56.2 – 68.4) | 602 | 58.7 | 3.2 | (52.4 – 65.0) |
| Mississippi | 321 | 50.5 | 4.6 | (41.5 – 59.5) | 320 | 51.9 | 4.6 | (42.9 – 60.9) |
| Missouri | 283 | 62.3 | 4.9 | (52.7 – 71.9) | 299 | 59.7 | 4.7 | (50.5 – 68.9) |
| Montana | 294 | 50.7 | 4.6 | (41.7 – 59.7) | 304 | 49.7 | 4.6 | (40.7 – 58.7) |
| Nebraska | 645 | 52.5 | 3.0 | (46.6 – 58.4) | 669 | 49.9 | 3.0 | (44.0 – 55.8) |
| Nevada | 163 | 50.1 | 6.4 | (37.6 – 62.6) | 182 | 45.1 | 6.1 | (33.1 – 57.1) |
| New Hampshire | 293 | 47.1 | 4.5 | (38.3 – 55.9) | 312 | 46.4 | 4.2 | (38.2 – 54.6) |
| New Mexico | 373 | 57.5 | 3.8 | (50.1 – 64.9) | 390 | 55.3 | 3.7 | (48.0 – 62.6) |
| New York | 194 | 51.9 | 6.0 | (40.1 – 63.7) | 214 | 47.3 | 5.9 | (35.7 – 58.9) |
| Ohio | 429 | 51.4 | 4.2 | (43.2 – 59.6) | 449 | 52.2 | 4.1 | (44.2 – 60.2) |
| Oklahoma | 254 | 46.0 | 4.7 | (36.8 – 55.2) | 265 | 43.3 | 4.6 | (34.3 – 52.3) |
| Oregon | 218 | 63.6 | 4.8 | (54.2 – 73.0) | 248 | 57.1 | 4.7 | (47.9 – 66.3) |
| Pennsylvania | 711 | 56.9 | 3.1 | (50.8 – 63.0) | 758 | 55.5 | 3.0 | (49.6 – 61.4) |
| Texas | 255 | 53.0 | 5.2 | (42.8 – 63.2) | 271 | 48.3 | 5.2 | (38.1 – 58.5) |
| Vermont | 270 | 57.7 | 4.4 | (49.1 – 66.3) | 284 | 54.8 | 4.3 | (46.4 – 63.2) |
| Washington | 523 | 59.4 | 3.2 | (53.1 – 65.7) | 551 | 58.1 | 3.1 | (52.0 – 64.2) |
| Wisconsin | 219 | 50.3 | 5.5 | (39.5 – 61.1) | 224 | 51.1 | 5.5 | (40.3 – 61.9) |
| 22 state total | 7,377 | 55.5 | 1.4 | (52.8 – 58.2) | 7,807 | 53.0 | 1.4 | (50.3 – 55.7) |
| Median | 53.7 | 52.4 | ||||||
| Range | 46.0-63.6 | 43.3-59.7 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval